Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Kraus

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Patient Education and Counseling|January 23, 2019
Implementation of patient education software in an anticoagulation clinic to decrease visit times for new patient appointmentsMaika I Patino, Peggy Kraus, Martin A Bishop
Medicine|September 7, 2019
Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendationsMona N Bahouth, Peggy Kraus, Kathryn Dane, et al.
The American Journal of Medicine|April 22, 2024
Inaccuracy of Initial Clinical Mobility Assessment in Venous Thromboembolism Risk StratificationErik H Hoyer, Aditya Bhave, Wingel Xue, et al.
Thrombosis Research|November 18, 2017
Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism preventionVictor O Popoola, Farrah Tavakoli, Brandyn D Lau, et al.
British Journal of Haematology|December 8, 2025
Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivorsBinish Javed, Jia Yu, Jenna Brown, et al.
Blood|May 22, 2023
Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognitionShruti Chaturvedi, Jia Yu, Jenna Brown, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Patient Education and Counseling|January 23, 2019
Implementation of patient education software in an anticoagulation clinic to decrease visit times for new patient appointmentsMaika I Patino, Peggy Kraus, Martin A Bishop
Medicine|September 7, 2019
Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendationsMona N Bahouth, Peggy Kraus, Kathryn Dane, et al.
The American Journal of Medicine|April 22, 2024
Inaccuracy of Initial Clinical Mobility Assessment in Venous Thromboembolism Risk StratificationErik H Hoyer, Aditya Bhave, Wingel Xue, et al.
Thrombosis Research|November 18, 2017
Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism preventionVictor O Popoola, Farrah Tavakoli, Brandyn D Lau, et al.
British Journal of Haematology|December 8, 2025
Risk factors for silent cerebral infarction in immune-mediated thrombotic thrombocytopenic survivorsBinish Javed, Jia Yu, Jenna Brown, et al.
Blood|May 22, 2023
Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognitionShruti Chaturvedi, Jia Yu, Jenna Brown, et al.
Pageof 1